mRNA |
Panobinostat |
CCLE |
pan-cancer |
AAC |
-0.2 |
2e-06 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
3e-06 |
mRNA |
Erlotinib |
CCLE |
pan-cancer |
AAC |
-0.2 |
2e-05 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
4e-05 |
mRNA |
lapatinib |
CCLE |
pan-cancer |
AAC |
-0.19 |
6e-05 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
9e-05 |
mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0001 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0002 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0002 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0002 |